|Bid||0.0000 x 1300|
|Ask||0.0000 x 1000|
|Day's Range||2.4700 - 2.7400|
|52 Week Range||1.8800 - 15.5200|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 13, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.50|
NTN Buzztime, Inc. (NYSE American: NTN) today announced that it plans to effect a one for two reverse stock split of its outstanding shares of common stock immediately prior to the closing of the merger with Brooklyn ImmunoTherapeutics LLC, which is anticipated to occur on March 25, 2021. The shares of common stock of the resulting company is expected to commence trading on March 26, 2021 on the NYSE American under the trading symbol "BTX".
NTN Buzztime, Inc. (NYSE American: NTN) today announced that its stockholders have approved the proposed merger between NTN and Brooklyn ImmunoTherapeutics LLC. The proposed merger remains subject to further customary closing conditions and regulatory approvals. NTN expects that the merger will close in the next two weeks.
NTN Buzztime, Inc. (NYSE American: NTN) today announced that leading independent proxy advisory firm Institutional Shareholder Services, Inc. ("ISS") recommends that NTN stockholders vote "FOR" ALL PROPOSALS to be considered and voted on at the March 15, 2021 special meeting of stockholders, all of which relate to the proposed merger involving NTN and Brooklyn ImmunoTherapeutics LLC ("Brooklyn") and the proposed sale of NTN's assets to eGames.com Holdings LLC ("eGames.com").